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Abstract Anandamide, an endogenous cannabinoid receptor
ligand, was rapidly metabolized by Tetrahymena pyriformis in
vivo. Metabolic products were mainly phospholipids as well
as neutral lipids, including small amounts of free arachidonic
acid. Anandamide amidohydrolase activity was detected in the
culture medium by the release of [3H]arachidonic acid from
[3H]anandamide, in a time- and concentration-dependent man-
ner. Kinetic experiments demonstrated that the released enzyme
had an apparent Km of 3.7 WM and Vmax 278 pmol/min/mg
protein. Amidohydrolase activity was maximal at pH 9^10,
was abolished by phenylmethylsulfonyl fluoride and was Ca2+-
and Mg2+-independent. Thus, T. pyriformis is capable of
hydrolyzing anandamide in vivo and releasing amidohydrolase
activity. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Anandamide (N-arachidonoylethanolamide) is the most
representative member of an emerging class of endogenous
lipids, including amides and esters of long-chain fatty acids,
termed collectively ‘endocannabinoids’, that have been re-
cently suggested to have a physiological role [1]. Anandamide
has been isolated from the brain lipids of various mammalian
species [2,3].
Endocannabinoids are capable of binding to cannabinoid
receptors and of eliciting cannabinimetic responses [4], such
as neuromodulatory e¡ects [5,6], inhibition of cancer cell
growth while they also a¡ect reproductive functions [5,7]
and modulate immune responses [5].
Anandamide is released from N-arachidonoylphosphatidyl-
ethanolamine by the action of a phospholipase D-like enzyme
[5,8]. It is inactivated by re-uptake by cells followed by hy-
drolysis (to arachidonic acid (AA) and ethanolamine) and/or
esteri¢cation process [5,9]. The enzyme responsible for the
hydrolysis (anandamide amidohydrolase, recently named fatty
acid amidohydrolase, FAAH) is found in various mammalian
tissues including brain liver and kidney and cell lines [10^16].
The enzyme is localized on microsomal and mitochondrial
membranes [3,11,17] and is likely to be the same amidase
previously shown to catalyze the hydrolysis of saturated and
monounsaturated amides [18].
Anandamide amidohydrolase has been suggested to be
identical to the enzyme catalyzing oleamide hydrolysis which
was cloned from a cDNA library of rat liver by Cravatt et al.
[19]. A recombinant enzyme overexpressed by transfection in
host cells was more active with anandamide than oleamide
[19]. Moreover, recently, it has been shown that the same
enzyme causes the hydrolysis of another endogenous canna-
binimetic compound, 2-arachidonoyl glycerol, to AA and
glycerol [20].
Cannabinoids elicit biological action in invertebrates [21]
which also contain anandamide as well as other endocanna-
binoids and its precursors [8,22^24]. For example, it has been
suggested that anandamide may be an oocyte-derived canna-
binimetic regulator of sea urchin fertility [23] and a physio-
logical stimulant of NO release in invertebrate ganglia [25].
Furthermore, FAAH activity has been found in invertebrates
such as Mytilus and leech [5].
Interestingly, it has been reported that THC (v9-tetrahydro-
cannabinol) elicited an e¡ect on movement, cellular growth
and division in Tetrahymena pyriformis [26,27]. Tetrahymena
species are widely used models for studies in diverse ¢elds of
biochemistry and molecular biology including lipid metabo-
lism and enzyme secretion. It has been known that Tetrahy-
mena releases large amounts of proteases, nucleases, glucosi-
dases, lipases and phospholipases [28]. The release process
takes place in both media and dilute salt solutions [29].
In the present study, we report the existence of anandamide
amidohydrolase activity in the unicellular eukaryote T. pyri-
formis. Furthermore, we show that the enzyme is secreted
from the cell into the medium. To our knowledge, the exis-
tence of a secreted form of the enzyme as well as the presence
of anandamide amidohydrolase in simple eukaryote has not
been reported.
2. Materials and methods
2.1. Materials
[3H]Anandamide (200 Ci/mmol) and [3H]AA (30 mCi/mmol) were
purchased from American Radiolabeled Chemicals Inc. (MO, USA).
Phenylmethylsulfonyl £uoride (PMSF), dithiothreitol (DTT), 5,5P-di-
thio-di(2-nitrobenzoic-acid) (DTNB), ca¡eic acid, acetylsalicylic acid,
palmitoyl chloride and oleoyl chloride were from Sigma. Other chem-
icals were of the highest purity available.
2.2. Cell cultures
T. pyriformis, strain W was cultured at 25‡C under constant stirring
in a medium consisting of 2% proteose^peptone, 0.5% dextrose, 0.2%
yeast extract and 1% 9 mM Fe2^EDTA (pH 5.5). At the end of the
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logarithmic phase (approximately 60 h), cells were harvested by cen-
trifugation at 500Ug for 10 min, the cell pellet was washed using
5 mM Tris^HCl (or saline), pH 9, and resuspended in the same so-
lution (2.5^3.0U106 cells/ml).
2.3. In vivo metabolism of [3H]anandamide, lipid analysis
T. pyriformis cells (2.5^3.0U106 cells/ml) were incubated for di¡er-
ent time intervals with [3H]anandamide (5U10310 M, 1 WCi/ml). Ali-
quots of 1.0 ml were washed twice with NaCl 0.9% (w/v) and the
lipids were extracted according to the Bligh^Dyer method [30]. Lipids
were then separated by thin-layer chromatography (TLC) on heat-
activated silica-gel G plates using CHCl3/CH3OH/NH4OH (28%)
80:20:2 (v/v) and were visualized by exposure to iodine vapors. Bands
corresponding to anandamide and its metabolic products (e.g. free
AA, phospholipids (PL), neutral lipids (NL)) were scraped o¡ the
plate and the radioactivity was quantitated by liquid scintillation
counting using 5 ml of a toluene-based scintillation £uid, in a liquid
scintillation counter (Wallac 1209 Rackbeta of Pharmacia). Metha-
nol^water phase containing soluble metabolites was also assayed for
radioactivity by counting 100-Wl aliquots, using 10 ml of a dioxan-
based scintillation £uid.
2.4. FAAH-activity assay in the medium
Cells, harvested as described above, were resuspended in Tris^HCl,
pH 9, bu¡er or alternatively in saline (2.5^3.0U106 cells/ml) and
remained at room temperature for 30 min under constant stirring.
Cells were then removed by centrifugation (500Ug for 10 min) and
the supernatant was incubated with [3H]anandamide (5U10310 M,
1 WCi/ml) in 1 ml ¢nal volume for 10 min unless stated otherwise.
The rate of cleavage of [3H]anandamide was determined by measuring
the radioactivity incorporated into AA and other metabolic products
as described for the in vivo metabolism (Section 2.3).
In some experiments, the cell medium was centrifuged at 100 000Ug
for 1 h and tested for amidohydrolase activity.
The in£uence of metal ions and inhibitors on the hydrolytic activity
was investigated after preincubation of the cell medium with the ap-
propriate concentrations of the reagent solution at 25‡C for 5 min.
Other FAAH substrates (N-oleoylethanolamine, N-palmitoylethanol-
amine) were added simultaneously with [3H]anandamide.
Protein was measured by the method of Lowry et al. [31].
The integrity of the cells was tested by assay of lactate dehydroge-
nase (LDH) [32] in the medium and observation under the micro-
scope.
2.5. Synthesis of N-oleoylethanolamine and N-palmitoylethanolamine
Oleoyl/palmitoyl chloride was dissolved in methylene chloride and a
10-fold molar excess of ethanolamine was added. The reaction took
place at 0^4‡C, under nitrogen, for 15 min and was terminated by the
addition of water. The organic phase was dried under vacuum and the
product was puri¢ed by TLC using CHCl3/CH3OH/NH4OH (28%)
80:20:2 (v/v/v) as the solvent system (Rf = 0.7) [2].
The structure of N-oleoylethanolamine was veri¢ed with 1H-NMR
spectra using a Varian NMR Unity Plus, 300 MHz. The main peaks
of 1H-NMR were a singlet at 5.9^6 ppm (^NH^CNO), a multiplet at
5.4 ppm (^CHNCH^), a triplet at 0.9 ppm (^CH3) and a singlet at
1.3^1.4 ppm. In addition, 13C-NMR results con¢rmed those obtained
with 1H-NMR (not shown).
The structure of N-palmitoylethanolamine was veri¢ed with electro-
spray mass spectrometry using a Finning Quadruple MAT SSQ700.
There was one main peak at m/z 300.3 which corresponds to the
[M+H].
3. Results
3.1. In vivo metabolism of [3H]anandamide
[3H]Anandamide was taken up and rapidly metabolized by
T. pyriformis W cells. The main metabolic products were PLs
commigrating with phosphatidylethanolamine on TLC and
other more polar PL, while a signi¢cant amount of radioac-
tivity was incorporated into NL (Rf = 0.9^1). After 5 min,
95% of [3H]anandamide was metabolized since only 5% of
the total radioactivity remained in anandamide and the radio-
activity of PL and NL was 70% and 20% respectively (Fig. 1).
At the same time, the percentage of radioactivity correspond-
ing to AA was very low (6 6%) (Fig. 1). These results clearly
show that anandamide was rapidly hydrolyzed to [3H]AA and
probably ethanolamine by the action of an amidohydrolase-
like activity, and AA and/or its metabolite(s) was then incor-
porated into various lipids. Preincubation of the cells with
PMSF (2 mM) for 15 min resulted to the inhibition of anan-
damide metabolism at a great extent since 83.6 þ 5.0% of the
total radioactivity remained in anandamide after 5 min. Only
a small amount of radioactivity was found in polar lipids and
free fatty acid (2.6 þ 0.7% up to 6 h), indicating that
[3H]anandamide was not hydrolyzed to AA by an amidohy-
drolase in the presence of PMSF (Fig. 1). Interestingly, a
signi¢cant amount of radioactivity remained incorporated
into NL (17.7 þ 5.2% in 5 min) even in the presence of
PMSF, but their identity has not been elucidated.
Fig. 1. Metabolic fate of [3H]anandamide in intact cells. T. pyrifor-
mis cells were incubated with 5U10310 M [3H]anandamide at 25‡C.
At the indicated times, a 1 ml aliquot of the suspension was re-
moved and lipids were extracted and subjected to TLC and radioac-
tivity was measured as described in Section 2. (b) NLs, (F) ananda-
mide, (8) PLs, (R) phosphatidylethanolamine, (S) free AA.
Results are expressed as mean þ S.E.M. of three to six experiments
performed in duplicates. Insert: The degradation of [3H]ananda-
mide.
Fig. 2. Anandamide amidohydrolase activity in the medium of T.
pyriformis cells. The medium (100 Wg/ml protein) was incubated at
30‡C in 0.05 M Tris^HCl bu¡er, pH 9, containing [3H]anandamide
(5U10310 M). At the indicated times, aliquots of the incubation
mixture were collected and lipids were extracted, separated on TLC
and their radioactivity was measured as described in Section 2. (R)
Free AA, (F) anandamide, (S) PMSF. Data represent means þ
S.E.M. of four to eight experiments performed in duplicate.
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3.2. Release of amidohydrolase activity in the culture medium
The rapid hydrolysis of [3H]anandamide led us to test the
hypothesis that anandamide was attacked by the enzyme ex-
tracellularly. Thus, T. pyriformis cells were harvested and
transfered into inorganic medium. After 30 min of incubation
under constant stirring, cells were removed by centrifugation
and the supernatant was tested for amidohydrolase activity.
Almost 80% of anandamide was metabolized to AA (60% of
the total radioactivity) (Fig. 2), while 10^15% was found in
the water^methanol phase of the Bligh^Dyer extraction after
10 min (not shown). The metabolic fate of [3H]anandamide in
the supernatant indicates that T. pyriformis cells are capable
of releasing enzyme(s) in the medium which is responsible for
anandamide hydrolysis. PMSF inhibited almost thoroughly
the hydrolysis showing the presence of amidohydrolase activ-
ity (Table 1; Fig. 2). Anandamide hydrolysis was not a¡ected
by the addition of EGTA, EDTA or Mg2, showing that the
activity was not dependent on Ca2 or Mg2 (Table 1). It was
also una¡ected by the presence of DTT or DTNB, suggesting
that sulfhydryl groups do not play important role in the ac-
tivity. [3H]Anandamide metabolism remained the same after
preincubation with cafeic acid, indomethacin and acetylsali-
cylic acid at the indicated concentrations (Table 1), suggesting
the absence of lipoxygenase (LOX) and cycloxygenase (COX)
activity. The hydrolysis of anandamide was dependent on
the temperature with optimum between 20 and 30‡C (not
shown) and also on pH, exhibiting a pH optimum at 9^10
(Fig. 3).
The rate of anandamide hydrolysis increased depending on
the protein amount. The extent of the metabolism was a linear
function of protein concentration between 0 and 85 Wg/ml,
while at higher concentrations, a plateau was reached (Fig.
4). It also varied with the substrate concentration. The appar-
ent Km of hydrolysis was 3.7 WM and the Vmax in the medium
of T. pyriformis cells was 278 pmol/min/mg protein (Fig. 5).
To test the substrate speci¢city, we synthesized N-palmitoyl-
ethanolamine and N-oleoylethanolamine and found that at
pH 9 the supernatant of T. pyriformis could also hydrolyze
N-palmitoylethanolamine and N-oleoylethanolamine (Table 1).
The absence of LDH activity in the medium (not shown)
indicated the integrity of the cells, suggesting that the hydro-
lytic activity was not due to membrane vesicles that may have
leaked out of the cells.
In addition, in some experiments the hydrolytic activity of
the supernatant obtained after centrifugation of the condi-
tioned medium at 100 000Ug for 1 h was also tested. The
results showed that V73 þ 20% (n = 6) of the total activity
was recovered in the supernatant solution.
Table 1
E¡ects of various compounds on FAAH activity
Inhibitor Activity pmol/min/mg protein % Inhibition of anandamide degradation
^ 0.3 þ 0.04 ^
PMSF (0.2 mM) 0.05 þ 0.02 83.9 þ 4.0
N-Palmitoylethanolamine (5U10310 M) 0.015 þ 0.004 95 þ 7.0
N-Oleoylethanolanine (5U1039 M) 0.010 þ 0.002 96.7 þ 2.0
EGTA (2 mM) 0.35 þ 0.01 ^
EDTA (2 mM) 0.3 þ 0.01 ^
DTT (0.33 mM) 0.25 þ 0.00 16.7 þ 0.0
DTNB (0.1 mM) 0.29 þ 0.00 3.3 þ 0.0
Cafeic acid (0.3 mM) 0.29 þ 0.01 3.3 þ 0.0
Acetylsalicylic acid (0.1 mM) 0.32 þ 0.03 ^
Indomethacin (1033 mM) 0.3 þ 0.01 ^
Mg2 (1 mM) 0.3 þ 0.00 ^
Fig. 3. pH-dependence of the hydrolysis of anandamide. The me-
dium (100 Wg/ml) was incubated with [3H]anandamide (5U10310 M)
at the indicated pH for 10 min. The bu¡ers (50 mM) used were: cit-
rate acid/sodium citrate at pH 4.0, 5.0, 6.0 (F), KH2PO4 at pH 6.0,
7.0, 8.0 (R), Tris^HCl at pH 8.0, 9.0, 10.0 (S), and NaHCO3 at
pH 10.0, 11.0 (8). Lipids were extracted, separated on TLC and ra-
dioactivity was measured. Other details in Fig. 2. Results from one
representative experiment of four experiments performed in dupli-
cate.
Fig. 4. Anandamide amidohydrolase activity as a function of pro-
tein concentration. [3H]Anandamide (5U10310 M) was incubated
with di¡erent protein amounts of T. pyriformis medium for 10 min.
Results from one of three experiments performed in duplicate. In-
sert : Metabolism of anandamide from 0 to 90 Wg protein.
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4. Discussion
In this study we report that a unicellular organism, the
protozoon T. pyriformis, is able to incorporate and rapidly
metabolize [3H]anandamide. The main metabolic products
were [3H]PL and [3H]NL (Fig. 1). The production of
[3H]PL was totally inhibited by the addition of PMSF (a
known serine protease inhibitor), suggesting the presence of
FAAH activity in intact T. pyriformis cells. It has been shown
that FAAH is a serine hydrolase [33,34]. FAAH activity re-
sults in the degradation of [3H]anandamide to ethanolamine
and [3H]AA, which is probably rapidly incorporated into PLs
and non-polar lipids since the levels of free [3H]AA were very
low. The production of [3H]NL in signi¢cant amounts even in
the presence of PMSF could be attributed to the direct me-
tabolism of anandamide by other enzymes, rather than
through AA, since it was only partially inhibited in the pres-
ence of PMSF.
It should be noted that AA was not considered a constitu-
ent of PL or NL of T. pyriformis [35], but it has been recently
shown that lipids of T. pyriformis may contain AA [36]. The
possibility that [3H]AA is converted to other fatty acid(s) (e.g.
linoleic acid which is a major constituent of T. pyriformis PLs
[35]) and then incorporated into PL could not be excluded.
The rapid metabolism observed in intact cells (Fig. 1, insert)
led us to hypothesize that the hydrolysis might start extracel-
lularly. It is well established that Tetrahymena species secrete
large amounts of hydrolytic enzymes. The enzyme secretion
has been shown to take place in growth media as well as in
starvation medium and the major types of released enzymes
are acid phosphatases, proteases, nucleases, glucosidases, li-
pases and phospholipases [29,37]. In the present work we
demonstrated that, indeed, T. pyriformis starvation medium
contained FAAH activity (Fig. 2) and we have characterized
the enzyme.
The hydrolysis products (chloroform-rich phase of Bligh^
Dyer extraction) were mainly [3H]AA as expected (Fig. 2),
while a relatively small percentage of radioactivity (6 15%,
not shown) was found in the methanol^water phase. The lat-
ter could be due to small amounts of [3H]anandamide and/or
[3H]AA produced by the enzyme since extraction of
[3H]anandamide or [3H]AA in the absence of cells or medium
resulted in approximately 10% of radioactivity in the water^
methanol phase (not shown). However, we cannot rule out the
possibility that soluble products of oxidative degradation of
[3H]anandamide and/or [3H]AA were formed to some extent,
the identity of which has not been established yet. Thus, we
can conclude that a FAAH activity released from T. pyrifor-
mis converts [3H]anandamide to [3H]AA and ethanolamine as
it has been shown for the enzyme derived from a variety of
mammalian cells [3,10^16].
Furthermore, the hydrolytic activity of T. pyriformis me-
dium was PMSF sensitive (Fig. 2; Table 1), suggesting that
the enzyme is a serine hydrolase as it is well established for
FAAH (or amidohydrolase) derived from mammalian cells
and/or tissues [3]. DTT and DTNB had no e¡ect on the en-
zymatic activity, suggesting that the sulfhydryl groups do not
play an important role in the mechanism of action of the
enzyme and was not Mg2- or Ca2-dependent since the ac-
tivity was not a¡ected by the presence of chelators (EGTA or
EDTA) (Table 1). It has been reported that FAAH activity in
mammalian cells is Mg2- or Ca2-independent [11,38].
It has been shown that anandamide could be a substrate for
both LOX and COX in mammalian cells [39^41]. Our results
show that ca¡eic acid and acetylsalicylic acid or indomethacin
did not a¡ect the activity, suggesting the absence of LOX- and
COX-like activity (Table 1).
The hydrolytic activity was abolished by boiling, and ki-
netic studies showed that the enzyme followed Michaelis^
Menten kinetics, yielding an apparent Km of 3.7 WM and a
Vmax equal to 278 pmol/min/mg protein. As it has been re-
ported from similar kinetic studies on the FAAH from vari-
ous cell types and tissues, there is a wide range of Km and
Vmax values (0.3^400 WM and 0.015^5.6 nmol/min/mg protein
respectively [3,10,11,14,24,42,43]). The kinetic values of our
enzyme are similar to those reported for rat and human brain
enzymes (3.4 WM [11] and 2 WM respectively [44]).
The unsaturated and monounsaturated analogues of anand-
amide (N-palmitoyl and N-oleoylethanolamine) completely
inhibited [3H]anandamide metabolism by T. pyriformis me-
dium, suggesting that the enzyme is not speci¢c for anand-
amide, as it has been reported for rat and porcine brain
microsomes [3,10].
Finally, it should be mentioned that LDH activity was ab-
sent from the medium and that most of the total hydrolytic
activity found in the medium remained in solution after cen-
trifugation at 100 000Ug, suggesting that the activity was not
due to membrane vescicles that may have leaked out of the
cells.
Nevertheless, the mechanism by which the enzyme is se-
creted as well as its subcellular origin were not addressed in
this work and further studies are required. Tetrahymena has at
least two secretory pathways that are well characterized: a
constitutive release mechanism and another responsible for
the release of hydrolytic enzymes apparently from lysosomes
[45]. Interestingly, Tetrahymena also possesses a regulated mu-
cocyst-mediated pathway in which a dense core vesicle (mu-
cocyst) is stably docked at the plasma membrane, at the site
of exocytosis. The use of mutants that are available [46] will
allow us to clarify the origin of the secreted FAAH-like ac-
tivity.
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Fig. 5. Anandamide amidohydrolase activity as a function of sub-
strate concentration. T. pyriformis supernatant (100 Wg/ml) was incu-
bated with di¡erent concentrations of [3H]anandamide at pH 9 for
10 min. Results are from one of three experiments performed in du-
plicate. Insert: Lineweaver^Burk.
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